文献速递糖尿病

糖尿病前期与临床结局风险升高相关,即便未进展为糖尿病

Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
PubMed 文献 · Diabetologia · 2024-11-12

基于ARIC研究10310名基线无糖尿病成人,中位随访约30年,糖尿病前期与任何并发症风险轻度相关(HR 1.21),在考虑进展为糖尿病后关联仍显著(HR 1.18),85%的过剩风险残留。进展为糖尿病仅解释不到四分之一的糖尿病前期相关临床结局风险。

要点

  • 糖尿病前期与任何并发症风险轻度相关(HR 1.21,95%CI 1.15-1.27)。
  • 考虑进展为糖尿病后关联仍显著(HR 1.18,95%CI 1.12-1.24)。
  • 85%的过剩风险在糖尿病前期中残留,进展为糖尿病解释不足四分之一。

核心结论

  • 进展为糖尿病解释不到四分之一的糖尿病前期相关临床结局风险。
  • 糖尿病前期即便未进展为糖尿病也贡献临床结局风险。

研究设计与样本

  • 来自ARIC研究的10310名基线无糖尿病参与者,年龄46-70岁,约55%女性,约20%黑人成人,基线1990-1992年。
  • 使用Cox回归分析糖尿病前期与约30年并发症发病率的年龄和性别调整关联,并将糖尿病发病作为时变变量建模。

主要发现

  • 基线时60%成人有糖尿病前期,其中约30%进展为糖尿病,中位进展时间7年。
  • 最大随访约30年期间共7069例事件:1937例ASCVD、2109例心力衰竭、3288例CKD和4785例死亡。
  • 糖尿病前期与任何并发症风险轻度相关(HR 1.21,95%CI 1.15-1.27)对比血糖正常。
  • 考虑进展为糖尿病后关联仍显著(HR 1.18,95%CI 1.12-1.24),85%(95%CI 75-94%)的任何并发症过剩风险在糖尿病前期中残留。
  • 各单独并发症结果相似。

关键数值与推荐

  • 糖尿病前期定义:HbA1c 39-47 mmol/mol(5.7-6.4%)或空腹血糖5.6-6.9 mmol/l。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Prediabetes (HbA1c 39-47 mmol/mol [5.7-6.4%] or fasting glucose 5.6-6.9 mmol/l) is associated with elevated risks of microvascular and macrovascular complications. It is unknown to what extent these risks in prediabetes remain after accounting for progression to diabetes. METHODS: In 10,310 participants from the Atherosclerosis Risk in Communities (ARIC) Study (aged 46-70 years, ~55% women, ~20% Black adults) without diabetes at baseline (1990-1992), we used Cox regression to characterise age- and sex-adjusted associations of prediabetes with ~30 year incidence of complications (composite and separately), including atherosclerotic CVD (ASCVD), heart failure, chronic kidney disease (CKD) and all-cause mortality before and after accounting for intervening incidence of diabetes, modelled as a time-varying variable. We calculated the excess risk of complications in prediabetes remaining after accounting for progression to diabetes. RESULTS: Of the 60% of adults with prediabetes at baseline, ~30% progressed to diabetes (median time to diabetes, 7 years). Over the maximum follow-up of ~30 years, there were 7069 events (1937 ASCVD, 2109 heart failure, 3288 CKD and 4785 deaths). Prediabetes was modestly associated with risk of any complication (HR 1.21 [95% CI 1.15, 1.27]) vs normoglycaemia. This association remained significant after accounting for progression to diabetes (HR 1.18 [95% CI 1.12, 1.24]) with 85% (95% CI 75, 94%) of the excess risk of any complication in prediabetes remaining. Results were similar for the individual complications. CONCLUSIONS/INTERPRETATION: Progression to diabetes explained less than one-quarter of the risks of clinical outcomes associated with prediabetes. Prediabetes contributes to the risk of clinical outcomes even without progression to diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Rooney MR, Wallace AS, Echouffo Tcheugui JB, et al. Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes. Diabetologia. 2024. PMID: 39531040. doi:10.1007/s00125-024-06315-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。